Pharsight

1. Lodoco patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10130585	AGEPHA PHARMA FZ	Methods of treating and/or preventing cardiovascular disease	Dec, 2034 (11 years from now)
US10206891	AGEPHA PHARMA FZ	Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent	Jan, 2035 (11 years from now)
US10265281	AGEPHA PHARMA FZ	Treatment or prevention of cardiovascular events via the administration of a colchicine derivative	Jan, 2035 (11 years from now)
US10842762	AGEPHA PHARMA FZ	Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent	Jan, 2035 (11 years from now)
US11026899	AGEPHA PHARMA FZ	Treatment or prevention of cardiovascular events via the administration of a colchicine derivative	Jan, 2035 (11 years from now)
US11026900	AGEPHA PHARMA FZ	Treatment or prevention of cardiovascular events via the administration of a colchicine derivative	Jan, 2035 (11 years from now)
US9744144	AGEPHA PHARMA FZ	Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent	Jan, 2035 (11 years from now)
US11026901	AGEPHA PHARMA FZ	Treatment or prevention of cardiovascular events via the administration of a colchicine derivative	Jan, 2035 (11 years from now)

Drugs and Companies using COLCHICINE ingredient

Market Authorisation Date: 16 June, 2023

Treatment: A method of treating cardiovascular disease; A method of treating and/or reducing the risk of a cardiovascular event; Acute coronary syndrome, out-of-hospital cardiac arrest, and/or noncardioembolic i...

Dosage: TABLET;ORAL